In part 3 of this Exclusive Interview, Dr. Linda Siminerio talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, California. Dr. Siminerio shares her choice for the most life-changing technology for patients.
Dr. Linda Siminerio RN, PhD is a Professor of Medicine at the University of Pittsburgh and Executive Director of the University of Pittsburgh Diabetes Institute.
Transcript of this video segment:
Steve: If you had to pick one piece of technology that has made the most difference in the care of a person with diabetes what would you say that technology would be?
Dr. Siminerio: Continuous blood glucose monitoring
Steve: More so than the blood glucose monitor?
Dr. Siminerio: Oh gosh, that’s a tough question, because at the time that was groundbreaking.
Steve: If you had the two together right now your decision would be CGM?
Dr. Siminerio: Yeah. Well, actually I will give an answer that might be broader than that. Probably whenever we began using and understanding HbA1c levels. Because before we knew about HbA1c levels, we had no idea. And that’s what led us to have the ability to do the studies that we did. Without A1c, we had no parameters at all.
Steve: It’s interesting because if go back to the DCCT trials and when you add the A1c and the expression “comprehensive tight control” it made a huge difference in how we treat patients, would you agree with that?
Dr. Siminerio: Yes, and without the A1c it would have been really hard to do the DCCT. I guess that to me, was one of the sentinel moments is when A1c was made available.